AETERNA ZENTARIS INC has a total of 16 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Iceland, Norway and Finland. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are AETERNA LAB INC, LAB AETERNA INC and ASAC COMPANIA DE BIOTECNOLOGIA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Iceland | 3 | |
#2 | Norway | 3 | |
#3 | Finland | 2 | |
#4 | United States | 2 | |
#5 | Hong Kong | 1 | |
#6 | Hungary | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Taiwan | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Specific use of cosmetics | |
#4 | Unspecified technologies | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Dupont Eric | 14 |
#2 | Juneau Christina | 9 |
#3 | Brazeau Paul | 8 |
#4 | Marenus Kenneth | 6 |
#5 | Berube Jocelyn | 3 |
#6 | Meas Daniel H | 3 |
#7 | Maes Daniel H | 3 |
#8 | Ammer Nicola | 1 |
#9 | Muller Gilbert | 1 |
#10 | Sachse Richard | 1 |
Publication | Filing date | Title |
---|---|---|
US10288629B1 | Method of assessing growth hormone deficiency in humans by a macimorelin containing composition | |
WO2006059236A2 | Method of using cartilage extract for increasing blood parameters |